Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,016 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Active Surveillance plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128-36: Let's Not Go Back in Time! What Have We Learned in the Treatment of Localized Prostate Cancer? Applicability of the ENACT Randomized Clinical Trial in Clinical Practice.
Gómez Rivas J, Gandaglia G, Montorsi F. Gómez Rivas J, et al. Among authors: montorsi f. Eur Urol Open Sci. 2022 Nov 14;46:135-136. doi: 10.1016/j.euros.2022.09.022. eCollection 2022 Dec. Eur Urol Open Sci. 2022. PMID: 36405303 Free PMC article. No abstract available.
Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer.
Briganti A, Joniau S, Gontero P, Abdollah F, Passoni NM, Tombal B, Marchioro G, Kneitz B, Walz J, Frohneberg D, Bangma CH, Graefen M, Tizzani A, Frea B, Karnes RJ, Montorsi F, Van Poppel H, Spahn M. Briganti A, et al. Among authors: montorsi f. Eur Urol. 2012 Mar;61(3):584-92. doi: 10.1016/j.eururo.2011.11.043. Epub 2011 Dec 2. Eur Urol. 2012. PMID: 22153925
Preoperative erectile function represents a significant predictor of postoperative urinary continence recovery in patients treated with bilateral nerve sparing radical prostatectomy.
Gandaglia G, Suardi N, Gallina A, Capitanio U, Abdollah F, Salonia A, Nava L, Colombo R, Guazzoni G, Rigatti P, Montorsi F, Briganti A. Gandaglia G, et al. Among authors: montorsi f. J Urol. 2012 Feb;187(2):569-74. doi: 10.1016/j.juro.2011.10.034. Epub 2011 Dec 15. J Urol. 2012. PMID: 22177170
Nerve-sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery.
Suardi N, Moschini M, Gallina A, Gandaglia G, Abdollah F, Capitanio U, Bianchi M, Tutolo M, Passoni N, Salonia A, Hedlund P, Rigatti P, Montorsi F, Briganti A. Suardi N, et al. Among authors: montorsi f. BJU Int. 2013 May;111(5):717-22. doi: 10.1111/j.1464-410X.2012.11315.x. Epub 2012 Jun 21. BJU Int. 2013. PMID: 22726993
Extended pelvic lymph node dissection does not affect erectile function recovery in patients treated with bilateral nerve-sparing radical prostatectomy.
Gandaglia G, Suardi N, Gallina A, Abdollah F, Capitanio U, Salonia A, Colombo R, Bianchi M, Chun FK, Hansen J, Rigatti P, Montorsi F, Briganti A. Gandaglia G, et al. Among authors: montorsi f. J Sex Med. 2012 Aug;9(8):2187-94. doi: 10.1111/j.1743-6109.2012.02812.x. Epub 2012 Jun 27. J Sex Med. 2012. PMID: 22738395
Postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve-sparing radical prostatectomy.
Gandaglia G, Albersen M, Suardi N, Gallina A, Abdollah F, Castiglione F, Capitanio U, Salonia A, Rigatti P, Hedlund P, Montorsi F, Briganti A. Gandaglia G, et al. Among authors: montorsi f. Int J Urol. 2013 Apr;20(4):413-9. doi: 10.1111/j.1442-2042.2012.03149.x. Epub 2012 Sep 12. Int J Urol. 2013. PMID: 22970988
2,016 results